Note: Ingredients listed on restricted chemical lists
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
0,0165 - 0,0204 %
General Information
Version
3.0
Revision date
2022-12-05
Product name
SYLGARD 184 Silicone Elastomer Curing Agent
1.2.1 Relevant identified uses
Vulcanising agents
Emergency telephone
00 33 388 736 000, 33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
DOW FRANCE S.A.S
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion@dow.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H360Fd
Hazard statements
Code
Statements
H360Fd
May damage fertility; Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
DANGER
Hazard statements
H360Fd May damage fertility. Suspected of damaging the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P234 Keep only in original packaging. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P403 Store in a well-ventilated place.
Contains
Methylvinylcyclosiloxane
2.3 Other hazards
May generate flammable hydrogen gas. Avoid contact with water, alcohols, acidic, basic, or oxidizing materials. This product contains octamethylcyclotetrasiloxane (D4) that has been identified by the Member State Committee of ECHA as fulfilling the PBT and vPvB criteria laid down in Annex XIII to Regulation (EC) No
Environmental hazards
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Human Health: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
